IL46629A - Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide - Google Patents

Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide

Info

Publication number
IL46629A
IL46629A IL46629A IL4662975A IL46629A IL 46629 A IL46629 A IL 46629A IL 46629 A IL46629 A IL 46629A IL 4662975 A IL4662975 A IL 4662975A IL 46629 A IL46629 A IL 46629A
Authority
IL
Israel
Prior art keywords
tablet according
tablet
group
trimethoprim
sulphonamide
Prior art date
Application number
IL46629A
Other languages
English (en)
Other versions
IL46629A0 (en
Original Assignee
Beaconoll Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL46629(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beaconoll Ltd filed Critical Beaconoll Ltd
Publication of IL46629A0 publication Critical patent/IL46629A0/xx
Publication of IL46629A publication Critical patent/IL46629A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL46629A 1974-02-14 1975-02-13 Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide IL46629A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (2)

Publication Number Publication Date
IL46629A0 IL46629A0 (en) 1975-05-22
IL46629A true IL46629A (en) 1977-07-31

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
IL46629A IL46629A (en) 1974-02-14 1975-02-13 Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide

Country Status (32)

Country Link
JP (1) JPS5545043B2 (no)
AT (1) AT344915B (no)
AU (1) AU468465B2 (no)
BE (1) BE825496A (no)
CA (1) CA980688A (no)
CH (1) CH618432A5 (no)
CS (1) CS220306B2 (no)
CY (1) CY1052A (no)
DD (1) DD118228A5 (no)
DE (1) DE2506099C2 (no)
DK (1) DK143247C (no)
DO (1) DOP1979002763A (no)
ES (1) ES434688A1 (no)
FI (1) FI62219C (no)
FR (1) FR2260993B1 (no)
GB (1) GB1499672A (no)
GT (1) GT197960431A (no)
HK (1) HK23980A (no)
HU (1) HU171536B (no)
IE (1) IE40599B1 (no)
IL (1) IL46629A (no)
IN (1) IN141019B (no)
KE (1) KE3038A (no)
LU (1) LU71835A1 (no)
MC (1) MC1053A1 (no)
MY (1) MY8100054A (no)
NL (1) NL157501C (no)
NO (1) NO146043C (no)
PH (1) PH14575A (no)
SE (1) SE427898B (no)
ZA (1) ZA75930B (no)
ZM (1) ZM1875A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
NO146043B (no) 1982-04-13
JPS5545043B2 (no) 1980-11-15
CS220306B2 (en) 1983-03-25
FR2260993A1 (no) 1975-09-12
GB1499672A (en) 1978-02-01
GT197960431A (es) 1981-05-05
HK23980A (en) 1980-05-09
ES434688A1 (es) 1977-04-01
HU171536B (hu) 1978-01-28
DK143247B (da) 1981-08-03
DE2506099C2 (de) 1983-11-03
NL7501680A (nl) 1975-08-18
PH14575A (en) 1981-09-24
CY1052A (en) 1980-08-01
IL46629A0 (en) 1975-05-22
DK52875A (no) 1975-10-06
CA980688A (en) 1975-12-30
IE40599B1 (en) 1979-07-04
JPS50116627A (no) 1975-09-12
DOP1979002763A (es) 1987-06-18
KE3038A (en) 1980-04-25
DE2506099A1 (de) 1975-08-21
IN141019B (no) 1977-01-08
AU7817075A (en) 1976-01-15
ZA75930B (en) 1976-01-28
MY8100054A (en) 1981-12-31
FI62219C (fi) 1982-12-10
DD118228A5 (no) 1976-02-20
IE40599L (en) 1975-08-14
AU468465B2 (en) 1976-01-15
CH618432A5 (en) 1980-07-31
ATA108475A (de) 1977-12-15
ZM1875A1 (en) 1975-12-22
BE825496A (fr) 1975-05-29
DK143247C (da) 1981-11-30
NL157501C (nl) 1981-07-16
NO146043C (no) 1982-08-04
MC1053A1 (fr) 1976-02-20
SE427898B (sv) 1983-05-24
FR2260993B1 (no) 1978-06-30
LU71835A1 (no) 1975-06-24
FI62219B (fi) 1982-08-31
SE7501595L (no) 1975-08-15
NO750467L (no) 1975-08-15
FI750398A (no) 1975-08-15
AT344915B (de) 1978-08-25
NL157501B (nl) 1978-08-15

Similar Documents

Publication Publication Date Title
US4209513A (en) Tablet formulation
US4562024A (en) Process for preparing granulate containing poorly compressible medicinally active matter
EP1847260B1 (en) Solid dispersion preparation
US5087454A (en) Ibuprofen tablet
IL46629A (en) Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide
JPH08208484A (ja) セファクロル含有医薬配合物
Karpe et al. Formulation development and evaluation of acyclovir orally disintegrating tablets
Adeleye et al. Evaluation of cissus gum as binder in a paracetamol tablet formulation
IE42952B1 (en) Tablet formulation
IE55579B1 (en) Processes for preparing tablets by a modified'wet-granulation'technique
Ford et al. Preparation, properties and ageing of tablets prepared from the chlorpropamide-urea solid dispersion
IE42958B1 (en) Tablet formulation
UA123552C2 (uk) Фармацевтична композиція, що містить комбінацію мемантину і мелатоніну
Johansson Influence of the granulation technique and starting material properties on the lubricating effect of granular magnesium stearate
Satyam et al. Isolation and evaluation of binding property of pappaya starch in diclofenac sodium tablet
JP5576963B2 (ja) 固体分散体製剤
Akpabio et al. Investigating Corchorus olitorius hydrocolloid as a novel matrix former in sustained release delivery of ibuprofen tablet
Bukke EXTENDED RELEASE TABLETS OF LAMIVUDINE: FORMULATION AND IN VITRO EVALUATION
Ologunagba et al. Formulation and evaluation of dispersible isoniazid tablets for paediatric use: an extemporaneous model formulary application in a resource limited setting
Paramasivam et al. Formulation and in vitro characterization of tapentadol HCL as immediate release tablets
Vasanthi et al. Design, formulation and evaluation of fexofenadine hcl immediate release tablets by solid dispersion method using solvent evaporation technique
Mohammed et al. Evaluating the Flow and Release Profiles of Ibuprofen Formulations by Increasing the Binder Concentration
Hackl et al. Effect of lubricants on the properties of tablets compressed from varied size granules
Kumar et al. Design development and evaluation of bi-layered tablet of Divalproex sodium.
Manthena et al. Formulation and evaluation of sustained release tablets of quinapril HCL